Research project

KETO-LUNG: assessing the impact of the adoption of a continuous ketogenic diet on the efficacy of combination chemo-immunotherapy using paclitaxel/carboplatin/pembrolizumab in advanced squamous cell cancer of the lung

Staff

Lead researchers

Professor Lynn Calman PhD, MPH, MRes, BSc (Hons), RN, FHEA

Professor

Research interests

  • For nearly 20 years Lynn’s research has focused on understanding and responding to the needs of people living with and beyond cancer. She had led and collaborated on major research programmes in cancer survivorship/psychosocial oncology leading to widely published, practice changing findings that have underpinned the development of services to improve the outcomes of cancer patients.
Connect with Lynn

Research outputs